Coronavirus live: “Highly unlikely” that U.K. variant isn’t locally present in India, say scientists

Weeks before the first COVID-19 infection was identified in India, the country is on it’s way to vaccinate millions of frontline workers from January 16. Vaccines would first reach four major depots in Karnal, Kolkata, Chennai and Mumbai, with all States having at least one State-level regional vaccine store.

Covishield and Covaxin, the two vaccines which are currently available, will be administered in two doses, with a gap of 28 days between each dose. The effectiveness will begin 14 days after the second dose. Citizens are expected to stick to COVID-19 appropriate behaviour during and after the vaccination process.

You can track coronavirus cases, deaths and testing rates at the national and State levels here. A list of State Helpline numbers is available as well.

Here are live updates:


102 people found infected with UK strain of coronavirus: Health Ministry

The number of people in India who have tested positive for the new UK variant of coronavirus has climbed to 102, the Union Health Ministry said on Wednesday.

Till January 11, the number of people affected by this strain of the coronavirus was 96.

On Wednesday, the ministry said, “The total number of persons found to be positive with the new UK variant genome stands at 102 today.” All these people were kept in single-room isolation in designated healthcare facilities by respective state governments. Their close contacts have also been put in quarantine and comprehensive contact tracing has been initiated for co-travellers, family contacts and others.

Genome sequencing on other specimens is going on, the ministry said, adding the situation is under careful watch and regular advice is being provided to the states for enhanced surveillance, containment, testing and dispatch of samples to INSACOG (Indian SARS-CoV-2 Genomics Consortium) labs, the ministry said. – PTI


India records 15,968 new cases

India’s COVID-19 caseload increased to 1,04,95,147 with 15,968 infections being reported in a day, while the recoveries have surged to 1,01,29,111 pushing the national recovery rate to 96.51%, according to the Union Health Ministry data updated on Wednesday.

The death toll increased to 1,51,529 with 202 daily new fatalities, the data updated at 8 a.m. showed. The number of people who have recuperated from the disease surged to 1,01,29,111 pushing the national COVID-19 recovery rate to 96.51%, while the COVID-19 case fatality rate stands at 1.44%.

The COVID-19 active caseload remained below 3 lakh. – PTI


Tardy hunt for UK variant of virus

Though the Union Health Ministry has confirmed the presence of 96 instances of the ‘UK variant’ — a form of the Sars-Cov2 associated with high infections — in India, it is yet to significantly begin looking for the variant in those without such history. So far these variants have only been identified in those with international travel history after November.

Scientists associated with the sequencing exercise, on condition of anonymity, told The Hindu that it was “highly unlikely” the variant wasn’t locally present in India in those without travel history and that not enough was being done to actively look for it.

Identifying such variants is important because in the event of a rapid spike in cases, it can be analysed if certain variants are responsible. It would also be necessary to grow these viruses in the lab so that scientists can then design appropriate tools to make diagnostic devices or even improve vaccine development efforts.


Emotional moment for Serum Institute of India team, says Poonawalla

Boxes of Covishield, the vaccine made at the Serum Institute of India, has left for multiple locations across India, Mr. Adar Poonawalla, CEO, SII, tweeted on Tuesday. “An emotional moment for the team at Serum Institute as the first shipments finally leave,” it said.

Adar Poonawalla tweeted: “An emotional moment for the team at @SerumInstIndia as the first shipments of #Covishield finally leave for multiple locations across India.” Photo: Twitter/@adarpoonawalla


The Centre has procured 11 million doses at ₹200 a dose. Two doses, 28 days apart, are to be given to 30 crore healthcare workers and others in priority groups identified by States. As part of the government-sponsored inoculation of health workers, 5.5 million doses of Covaxin, developed by Bharat Biotech, are also being procured.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *